Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Psychiatry
Volume 2014, Article ID 162502, 2 pages
http://dx.doi.org/10.1155/2014/162502
Case Report

Transient Serotonin Toxicity Evoked by Combination of Electroconvulsive Therapy and Fluoxetine

Psychiatric Centre Frederiksberg, Nordre Fasanvej 57-59, 2000 Frederiksberg, Denmark

Received 17 March 2014; Revised 9 May 2014; Accepted 12 May 2014; Published 1 June 2014

Academic Editor: Shusuke Numata

Copyright © 2014 René Klysner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Marley and K. M. Wozniak, “Interactions of a non-selective monoamine oxidase inhibitor, phenelzine, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake,” Journal of Psychiatric Research, vol. 18, no. 2, pp. 173–189, 1984. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Sternbach, “The serotonin syndrome,” The American Journal of Psychiatry, vol. 148, no. 6, pp. 705–713, 1991. View at Google Scholar · View at Scopus
  3. N. Okamoto, K. Sakamoto, and M. Yamada, “Transient serotonin syndrome by concurrent use of electroconvulsive therapy and selective serotonin reuptake inhibitor: a case report and review of the literature,” Case Reports in Psychiatry, vol. 2012, Article ID 215214, 3 pages, 2012. View at Publisher · View at Google Scholar
  4. R. Persson, “The serotonin syndrome—a case report,” Nordic Journal of Psychiatry, vol. 46, no. 2, pp. 117–119, 1992. View at Google Scholar · View at Scopus
  5. R. Lanzenberger, P. Baldinger, A. Hahn et al., “Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET,” Molecular Psychiatry, vol. 18, no. 1, pp. 93–100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. C. de Montigny, “Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin,” Journal of Pharmacology and Experimental Therapeutics, vol. 228, no. 1, pp. 230–234, 1984. View at Google Scholar · View at Scopus
  7. D. W. Costain, A. R. Green, and D. G. Grahame-Smith, “Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: relevance to the mechanism of the antidepressive effect of electroconvulsive therapy,” Psychopharmacology, vol. 61, no. 2, pp. 167–170, 1979. View at Google Scholar · View at Scopus